QIAGEN NV EO -,01
Stock
Stock
ISIN: NL0015002SN0
Ticker: QGEN
NL0015002SN0
QGEN
Price
Price
CHART BY
Historical dividends and forecast
The next dividend will be paid on 10.07.2026
$1.614
CHART BY
Frequently asked questions
What is QIAGEN NV EO -,01's market capitalization?
The market capitalization of QIAGEN NV EO -,01 is $10.04B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is QIAGEN NV EO -,01's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for QIAGEN NV EO -,01 is 23.77. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for QIAGEN NV EO -,01?
QIAGEN NV EO -,01's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.044. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for QIAGEN NV EO -,01's stock?
Currently, 24 analysts cover QIAGEN NV EO -,01's stock, with a consensus target price of $55.56. Analyst ratings provide insights into the stock's expected performance.
What is QIAGEN NV EO -,01's revenue over the trailing twelve months?
Over the trailing twelve months, QIAGEN NV EO -,01 reported a revenue of $2.09B.
What is the EBITDA for QIAGEN NV EO -,01?
QIAGEN NV EO -,01's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $715.37M. EBITDA measures the company's overall financial performance.
What is the free cash flow of QIAGEN NV EO -,01?
QIAGEN NV EO -,01 has a free cash flow of $453.28M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the free float of QIAGEN NV EO -,01's shares?
The free float of QIAGEN NV EO -,01 is 205.83M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $10.04B
- EPS (TTM)
- $2.044
- Free Float
- 205.83M
- P/E ratio (TTM)
- 23.77
- Revenue (TTM)
- $2.09B
- EBITDA (TTM)
- $715.37M
- Free Cashflow (TTM)
- $453.28M
Pricing
- 1D span
- $48.25$48.57
- 52W span
- $39.63$57.77
Analyst Ratings
The price target is $55.56 and the stock is covered by 24 analysts.
Buy
7
Hold
17
Sell
0
Information
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- NL0015002SN0
- Primary Ticker
- QGEN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet